Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Melinta Therapeutics, Inc. (NASDAQ:MLNT)

15.20
Delayed Data
As of 4:00pm ET
 -0.40 / -2.56%
Today’s Change
10.25
Today|||52-Week Range
37.00
+8.57%
Year-to-Date
Institutional investors lightened up their holdings of MLNT shares during the quarter ended September 2017 as they sold a net $533.6 thousand shares. Additionally, the 0.00% of shares outstanding that remains in their hands is below average for companies in the Pharmaceuticals: Other industry and highlights that this company is not an important holding.
Mutual fund holders0.00%
Other institutional0.00%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

9/30/2017PANAGORA ASSET MANAGEMENT, INC.  Bought 513.1 Thousand shares of Melinta Therapeutics, Inc...
9/30/2017TUDOR INVESTMENT CORP.  Bought 20.5 Thousand shares of Melinta Therapeutics, Inc...

Top 10 Owners of Melinta Therapeutics, Inc.

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Tudor Investment Corp.0.00%20,4980+20,498--
PanAgora Asset Management, Inc.0.00%513,0640+513,064--

Top 10 Mutual Funds Holding Melinta Therapeutics, Inc.

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
ProShares UltraPro Russell20000.00%500000.00%